RosiniRNicchiSPizzaM, et al. Vaccines against antimicrobial resistance. Front Immunol2020; 11: 1048.
5.
TadesseBTKeddyKHRickettNY, et al. Vaccination to reduce antimicrobial resistance burden-data gaps and future research. Clin Infect Dis2023;77(Suppl 7): S597–S607.
6.
LeiJPlonerAElfströmKM, et al. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med2020; 383(14): 1340–1348.
7.
OyouniAAA. Human papillomavirus in cancer: Infection, disease transmission, and progress in vaccines. J Infect Public Health2023; 16(4): 626–631.
8.
TsentemeidouAFyrmpasGStavrakasM, et al. Human papillomavirus vaccine to end oropharyngeal cancer. A systematic review and meta-analysis. Sex Transm Dis2021; 48(9): 700–707.
9.
KaoJH.Hepatitis B vaccination and prevention of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol2015;29(6): 907–917.
10.
MusherDMGrooverJEWatsonDA, et al. Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J Investig Med1997; 45(2): 57–68.
11.
ZhangWAhmadGMolehinAJ, et al. Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models. J Investig Med2018; 66(8): 1124–1132.
12.
HayneyMSPolandGAJacobsonRM, et al. The influence of the HLA-DRB1*13 allele on measles vaccine response. J Investig Med1996; 44(5): 261–263.
FreySE.Unique risks to volunteers in HIV vaccine trials. J Investig Med2003; 51(Suppl 1): S18–S20.
15.
GuoQYangQLiJ, et al. Advanced clinical trials of dendritic cell vaccines in ovarian cancer. J Investig Med2020; 68(7): 1223–1227.
16.
LuoCSChiCCFangYA, et al. Influenza vaccination reduces dementia in patients with chronic obstructive pulmonary disease: a nationwide cohort study. J Investig Med2020; 68(4): 838–845.
17.
MisraRJiobuKZhangJ, et al. Racial disparities in hepatitis B infection in Ohio: screening and immunization are critical for early clinical management. J Investig Med2013; 61(7): 1121–1128.
18.
ThomasDMRaySMMortonFJ, et al. Patient education strategies to improve pneumococcal vaccination rates: randomized trial. J Investig Med2003; 51(3): 141–148.
19.
BalianSBaileyBAbboudS, et al. Comparative admission rates and infection severity of COVID-19 among unvaccinated and vaccinated patients. J Investig Med2023; 71(4): 329–338.
20.
VanichkachornGGilmanEGaneshR, et al. Potential reduction of post-acute sequelae of SARS-CoV-2 symptoms via vaccination. J Investig Med2023; 71(8): 889–895.
21.
MonteroDAVidalRMVelascoJ, et al. Two centuries of vaccination: historical and conceptual approach and future perspectives. Front Public Health2024; 11: 1326154.